After delay, Kalvista wins FDA OK for drug to treat rare swelling disorder

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an on-time approval.

Trump says pharmaceutical, copper tariffs coming ‘very soon’

While Trump indicated drug levies would be set at a “very high” rate, he added that pharma firms would first be given time to bring manufacturing to the U.S.

Lilly gets FDA OK of modified dosing for Alzheimer’s drug

A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to prescribe Lilly’s amyloid-busting drug.

Medical groups, pregnant doctor sue RFK Jr. over vaccine changes

The complaint argues Kennedy’s actions to remove the COVID vaccine from the CDC's immunization schedule for pregnant people and healthy children were unlawful.

Novartis gets approval of first malaria medicine for newborns

Coartem Baby, which was cleared by health authorities in Switzerland, will fill an important gap in treatment. Novartis plans to sell it “largely” on a not-for-profit basis.

FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say

In first half of 2025, novel drug approvals are in line with previous years

US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy